WADA noted a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without any published conclusions. The FDA stated it lacks sufficient information to know whether the drug would cause harm when administered to humansan acknowledgment of uncertainty rather than proven danger, but one that acknowledges inability to rule out serious adverse effects including carcinogenic potential
doi: 10.1507/endocrj.43.suppl_s57 54 MllerNJrgensenJOL
~ AlphaMD The TRT Lifestyle Reset: Build Your Energy Routine from Scratch There comes a moment in every mans TRT journey when the goal shifts from "Will this work?" to "How do I live at my best every day?" The TRT Lifestyle Reset is your answer
Research news A University of Texas at El Paso study has found that people with type 2 diabetes or obesity who used glucagon-like peptide-1 receptor agonists had lower odds of alcohol, opioid, nicotine and cocaine use disorders, although researchers said clinical trials were needed before the drugs could be considered for addiction treatment A study led by researchers at The University of Texas at El Paso, USA, has found that the use of diabetes and weight loss medicines such as Ozempic was associated with a lower risk of alcohol, opioid, nicotine and cocaine use disorders
How is IGF-1 LR3 Administered
Q7: Does KLOW need to be cycled